APP and Alzheimer disease: To assess whether an excess of Aβ leads to alterations of Zn2+ levels in vivo, we visualized Zn2+ using Zinpyr-1 in hippocampal brain sections of APP-PS1 mice (3, 6 and 12 months of age) and AD patients.